Merck KGaA and Millipore Announce Transaction

Skadden is representing Merck KGaA in connection with its definitive agreement to acquire all outstanding shares of common stock of the Millipore Corporation for approximately US$7.2 billion. Merck KGaA is a global pharmaceutical and chemical company and Millipore is a leading Life Science company based in Massachusetts. The transaction, announced February 28, was approved by the boards of directors of both companies.